ADA and neoplasm: Various intrinsic factors affecting pharmacokinetics (PK) have been assessed in adults, including race, tumor type, age, creatinine clearance (37.1 to 272.2 mL/min), mild hepatic impairment, ECOG performance status, antidrug antibody (ADA), body weight, sex, and baseline albumin.